HSE to extend Soliris drug to PNH & aHUS patients – Deering
4th February 2015 - Fine Gael Press Office
Fine Gael Carlow/ Kilkenny TD, Pat Deering, has today (Wednesday) welcomed confirmation from the HSE that they are to extend access to the drug Eculizumab (trading as Soliris), for patients with the conditions Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Haemolytic Uraemic (aHUS).
“I have been advocating for this drug to be State funded ever since I heard the story of Ballinakill woman Mary Gorman who has PNH, a very rare and debilitating disease.
Related news
Statement from Fine Gael
“Both Fianna Fáil and Fine Gael negotiating teams met again today and made progress on various issues. “They will…
20th December 2024Statement from An Taoiseach
"The Fine Gael negotiating team and I held a very lengthy, constructive engagement with members of the Labour party, led…
16th December 2024Statement from Fine Gael and Fianna Fáil
Both Fianna Fáil and Fine Gael met today. It was a positive and constructive initial discussion on the future Programme…
11th December 2024